Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
224.9 USD | +2.21% | +3.27% | -13.07% |
May. 31 | Biogen: Brussels grants marketing authorization for Charcot disease | CF |
May. 31 | Disaster averted |
ETFs positioned on Biogen Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.30% | 1 M€ | -.--% | - | |
3.92% | 0 M€ | 0.00% | - | |
3.75% | 0 M€ | 0.00% | - | |
2.39% | 13,519 M€ | +3.20% | ||
2.28% | 4 M€ | +20.15% | ||
1.91% | 6 M€ | +16.84% | - | |
1.78% | 110 M€ | +8.20% | - | |
1.69% | 2 M€ | -.--% | ||
1.60% | 8 M€ | -.--% | ||
1.33% | 1,100 M€ | +2.49% | ||
1.30% | 9 M€ | -4.31% | - | |
1.00% | 14 M€ | -5.07% | ||
0.99% | 17 M€ | +6.09% | - | |
0.97% | 13 M€ | -.--% | - | |
0.97% | 3 M€ | +7.32% | - | |
0.97% | 1 M€ | +11.94% | - | |
0.94% | 204 M€ | +10.54% | ||
0.65% | 2 M€ | -25.75% | ||
0.64% | 8 M€ | +5.48% | - | |
0.48% | 4,592 M€ | -.--% | ||
0.44% | 1 M€ | +16.32% | ||
0.43% | 26 M€ | +16.85% | - | |
0.38% | 2 M€ | +20.44% | - | |
0.38% | 15 M€ | -.--% | - | |
0.37% | 5 M€ | -72.95% | - | |
0.37% | 9 M€ | -.--% | - | |
0.36% | 3 M€ | -.--% | - | |
0.29% | 92 M€ | +0.06% | - | |
0.29% | 469 M€ | -2.05% | ||
0.29% | 3,859 M€ | +18.82% | - | |
0.21% | 7 M€ | +5.60% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.07% | 32.75B | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B | |
-17.66% | 7.32B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.